

Clade I and II mpox virus is endemic in Central and West Africa, causing local seasonal outbreaks.
In May 2022, a new variant of the mpox virus caused the first global outbreak, prompting the World Health Organization (WHO) to declare a Public Health Emergency of International Concern, and causing nearly 90,000 cases worldwide in one year. This variant, known as clade IIb, differs from the mpox typically seen in Africa, particularly in how it spreads and the symptoms it causes.
With limited available clinical evidence about the disease’s symptoms and best treatments, researchers at PSI and the International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC) embarked with partners across Europe on a programme of research to generate robust and clinically significant new data.
Results from one of these studies on a large sample of participants, published in Clinical Infectious Diseases, provide insights into how clade IIb mpox affected people during the recent outbreak, the risks of onwards transmission and health outcomes for patients.
The observational study – known as MOSAIC and funded by the UK Foreign, Commonwealth and Development Office, Wellcome, the Bill & Melinda Gates Foundation and by the European Commission with the MPX-Response in the European Union – was conducted to better understand the clinical features of mpox and to measure how long it took for lesions to heal and for the virus to clear.
Read the full story on the Nuffield Department of Medicine website.
more recommended stories
Macrophage Microautophagy Supports Immune Readiness
A Breakthrough in Cellular Recycling Macrophages,.
The Role of α-Glucosidase in Type 2 Diabetes
α-Glucosidase Inhibition: Functional Food Compounds for.
Oral Bacteria Linked to Atherosclerosis
New Evidence Links Viridans Streptococci to.
CDI Test Shows Early Detection Potential in Alzheimer’s
Breakthrough Study Highlights Brain Blood Flow.
Prenatal Chlorpyrifos Exposure and Pediatric Brain Changes
A Growing Concern in Pediatric Neurodevelopment.
Valve Deterioration After TAVI: New Research Insights
The Growing Role of TAVI in.
FAST Walking Shows Promise in Post-Stroke Rehab
Stroke remains one of the leading.
Legionnaires’ Disease Long-Term Effects on Patient Recovery
Persistent Symptoms and Post-Acute Infection Syndromes.
Brisk Walking: A 15-Minute Daily Habit That Reduces Mortality in Underserved Populations
A powerful yet simple intervention A.
Vaping and Teen Smoking: UK Study Warns of Rising Risks
A new study published in Tobacco.
Leave a Comment